Call for Posters

Abstracts must be submitted by midnight ET on September 22, 2025.

Click the link below and use your pharmacist.com username and password to access the JFPS 2025 online abstract submission form:

https://site.pheedloop.com/portal/event/EVESNIXWRDHRV/submission/CALDFV6VG9PA724/application#start

Upon submission, the submitter will receive a confirmation email with the details of the submission.

You may update your abstract until September 22.

Abstract authors (up to 10) must be pharmacists or pharmacy technicians who are:

• Uniformed members of the Public Health Services, Veterans Administration, or Department of Defense
• Civilian pharmacists or technicians assigned to federal agencies.
• Retired or reserve members of the Army, Navy, Air Force, Coast Guard, Veterans Administration, or Public Health Service

Financial Disclosures

Financial disclosures for all abstract authors will be collected during the online abstract submission process. Authors must disclose all financial relationships within the prior 24 months.

Submit abstracts to one of the following 3 categories:

1. Contributed Research*: Abstracts present the findings of original research on issues relevant to practicing pharmacists and pharmacy technicians. Research with patients requires IRB approval.
2. Innovative Practice Report*: Practitioners who have implemented a new idea or strategy for the delivery of patient care, or a creative application of existing techniques or services, are encouraged to share their innovation with colleagues. This includes process improvement projects that show improved patient outcomes. Ideas and practices that are new to the region, system, or practice setting may be considered.
3. Encore Presentation: Submissions to this category must meet all submission and evaluation criteria for original papers, with the exception that the paper has been previously presented at a local, state, or national meeting within 12 months of the submission deadline. Submission requires the original presentation citation.               

*Projects in Progress: Projects in progress must have been started and in the process of collecting data or in the process of implementing an innovative practice or process improvement.  Completed data or initial outcomes must be presented at JFPS 2025.

Submit abstracts to one of the following topics:

1. Automation/Technology
2. Clinical Pharmacy
3. Hospital Inpatient Services
4. Pharmacy Operations
5. Readiness
6. Other/Emerging Topics

• Be as specific, descriptive, and thorough as possible about project/study design, methods, data collection and analysis, results, and conclusion/implications
• Use complete sentences
• Include background information to justify why this program was created
• Define time periods; include dates, where applicable
• Describe patient population(s)
• Define acronyms
• Avoid the use of jargon
• Check spelling and grammar
• Do not identify facility or unit in the body of the abstract

Abstracts submitted by September 22, 2025 will be reviewed by a group of federal pharmacy volunteers. All abstracts are subjected to a double-blind peer review. Each abstract will be evaluated according to the following criteria:

• Relevance – makes important contribution to federal pharmacy practice.
• Originality – new, innovative approaches to move the pharmacy profession forward.
• Clear statement of question(s) to be answered or objective(s) to be met.
• Study/project design – project design clearly stated, appropriate to achieve objectives, and variables controlled. Setting and patient population described.
• Methods and data collection process/analysis clearly descried. Source(s) of data, how it is being collected. Data analysis/evaluation procedures target project outcomes and support project objectives. Compare different strategies.
• Results – findings are reported for each objective or research question. Include data in your results section. (Projects in Progress must report any initial findings.)
• Conclusions are appropriately stated, based on results. (Projects in Progress will not include Conclusions on the abstract; however, conclusions should be included in the final poster presentation.)
• Implications of findings for pharmacy practice, policy theory, or further research are discussed and should focus on tangible or significant results. Describe how innovation is adaptable to other practice sites/settings. (Projects in Progress will describe potential implications.)

In mid-October, APhA will notify abstract authors about the status of their abstract submission. Emails will only be sent to the email address of the submitter’s pharmacist.com account. 

If you have not received notification by October 15, 2025 contact APhA.

Accepted abstracts will be invited to present a poster at JFPS 2025 in the Meet the Researchers session on November 17, 2025 in Fort Lauderdale, FL. Poster presenters are expected to register for and attend JFPS 2025 in person.

Because the “Meet the Researchers” session offers CPE credit, the poster presentations must comply with the policy set forth by the Accreditation Council for Pharmacy Education (ACPE).:

The Accreditation Council for Pharmacy Education’s Standards for Integrity and Independence in Accredited Continuing Education require that all continuing pharmacy education providers “…must ensure that all decisions related to the planning, faculty selection, delivery, and evaluation of accredited education are made without any influence or involvement from the owners and employees of an ineligible company.” “Ineligible companies” are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Everyone in a position to control the content of an education activity is required to disclose “all their financial relationships within the prior 24 months.” Financial relationships are those in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, or other financial benefit. Financial benefits usually are associated with roles such as: employment, management position, independent contractor (including contracted research), consulting, speaking, teaching, membership on advisory committee or review panel, board membership, or any other activities in which remuneration is received or expected.

Ownership interests (e.g., ownership of stocks, stock options, or similar interests, excluding diversified mutual funds) also qualify as financial relationships.

How does this translate to your poster and use of logos?

• Financial disclosures must be displayed on the poster
• NO logos for pharmaceutical companies
• OK to use logos for hospitals, universities, schools, health care networks
• OK to use logos for community pharmacies (e.g., Walgreens, Kroger) IF they are also a provider of clinical care directly to patients

Poster Awards

To be eligible for the JFPS 2025 poster award program, the following requirements must be met:

• The poster must be accepted for presentation.
• Poster presenters must submit a PDF of their final poster and an accompanying audio recording.

Posters are judged on Technical Merit, Originality, and Presentation.

Awardees will be announced at the Closing General Session.

Abstract Publication

Accepted abstracts that are presented at JFPS 2025 will be e-published in a 2026 issue of the Journal of the American Pharmacists Association (JAPhA) at www.japha.org. APhA holds first right of refusal for material contained in abstracts when submitted for publication. Full manuscripts that expand on the abstracts should be submitted for publication in an APhA publication, usually JAPhA at www.japha.org.  Encore presentations are not published in their entirety; only the title, authors, and original citation will appear.

For more information, please contact Ellyn Terry at eterry@aphanet.org.